Cazzaniga, M.E., Casadei, V., Cagossi, K., Cavanna, L., Cursano, M.C., De Conciliis, E.M.R., et al. (2017). Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study. JOURNAL OF CLINICAL ONCOLOGY, 35(15_suppl), e12552-e12552 [10.1200/JCO.2017.35.15_suppl.e12552].

Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study

Gebbia, Vittorio;RUSSO, Salvatore;Valerio, Maria Rosaria;
2017-05-30

30-mag-2017
ASCO Annual Meeting I
2017
53.
Cazzaniga, M.E., Casadei, V., Cagossi, K., Cavanna, L., Cursano, M.C., De Conciliis, E.M.R., et al. (2017). Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study. JOURNAL OF CLINICAL ONCOLOGY, 35(15_suppl), e12552-e12552 [10.1200/JCO.2017.35.15_suppl.e12552].
File in questo prodotto:
File Dimensione Formato  
screencapture-ascopubs-org-doi-10-1200-JCO-2017-35-15-suppl-e12552-2023-01-25-09_29_16.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 2.04 MB
Formato Adobe PDF
2.04 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/359925
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact